Eli Lilly & Co. (NYSE: LLY) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ELI LILLY & CO.

Eli Lilly & Co. (NYSE: LLY)
Listen to this Section


$1,146.13
+20.8640 ( +1.85% ) 2.5M

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Market Data


Open $1,146.13
Previous Close $1,125.27
Volume 2.5M
Market Cap $1,003.45B
Day Range $1,125.00 - $1,165.84
52 Week Range $623.78 - $1,165.84
Shares Outstanding 891.74M
Change % +1.85%
Net Change ▲ 20.8640
Insider Ownership N/A
Exchange NYSE
SectorBasic Materials
IndustryPHARMACEUTICAL PREPARATIONS
IPO Year1970
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 7,552.00

Date Type Amount Purchased Purchaser
2025-08-15 Buy 715.00 Montarce Lucas
2025-08-14 Buy 758.00 Alvarez Ralph
2025-08-14 Buy 758.00 Alvarez Ralph
2025-08-13 Buy 1000.00 Van Naarden Jacob
2025-08-12 Buy 1632.00 Ricks David A
2025-08-12 Buy 1000.00 Skovronsky Daniel
2025-08-12 Buy 117.00 Sulzberger Gabrielle
2025-08-12 Buy 686.00 Fyrwald J Erik
2025-08-12 Buy 686.00 Fyrwald J Erik
2025-08-08 Buy 200.00 JACKSON JAMERE

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 03, 2025
8-k 8K-related 15 Oct 30, 2025
10-q Quarterly Reports 73 Oct 30, 2025
4 Insider transactions 1 Oct 22, 2025
4 Insider transactions 1 Oct 22, 2025
4 Insider transactions 1 Oct 22, 2025
4 Insider transactions 1 Oct 22, 2025
4 Insider transactions 1 Oct 22, 2025
4 Insider transactions 1 Oct 14, 2025
4 Insider transactions 1 Oct 10, 2025

Latest News


× Before browsing our site, please accept our cookies policy